1 Study Coverage 1.1 Radioimmunotherapy Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Introduction 1.2 Global Radioimmunotherapy Outlook 2017 VS 2022 VS 2028 1.2.1 Global Radioimmunotherapy Market Size for the Year 2017-2028 1.2.2 Global Radioimmunotherapy Market Size for the Year 2017-2028 1.3 Radioimmunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Radioimmunotherapy in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Radioimmunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Radioimmunotherapy Market Dynamics 1.4.1 Radioimmunotherapy Industry Trends 1.4.2 Radioimmunotherapy Market Drivers 1.4.3 Radioimmunotherapy Market Challenges 1.4.4 Radioimmunotherapy Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Radioimmunotherapy by Type 2.1 Radioimmunotherapy Market Segment by Type 2.1.1 Non Hodgkin Lymphoma (NHL) 2.1.2 Follicular Lymphoma 2.1.3 Solid Tumors 2.1.4 Breast Cancer 2.1.5 Ovarian Cancer 2.1.6 Osteosarcoma 2.1.7 Neuroblastoma 2.1.8 Prostate Cancer 2.2 Global Radioimmunotherapy Market Size by Type (2017, 2022 & 2028) 2.3 Global Radioimmunotherapy Market Size by Type (2017-2028) 2.4 United States Radioimmunotherapy Market Size by Type (2017, 2022 & 2028) 2.5 United States Radioimmunotherapy Market Size by Type (2017-2028) 3 Radioimmunotherapy by Application 3.1 Radioimmunotherapy Market Segment by Application 3.1.1 Tumor Antigens 3.1.2 Radionuclides 3.1.3 Antibodies 3.2 Global Radioimmunotherapy Market Size by Application (2017, 2022 & 2028) 3.3 Global Radioimmunotherapy Market Size by Application (2017-2028) 3.4 United States Radioimmunotherapy Market Size by Application (2017, 2022 & 2028) 3.5 United States Radioimmunotherapy Market Size by Application (2017-2028) 4 Global Radioimmunotherapy Competitor Landscape by Company 4.1 Global Radioimmunotherapy Market Size by Company 4.1.1 Top Global Radioimmunotherapy Companies Ranked by Revenue (2021) 4.1.2 Global Radioimmunotherapy Revenue by Player (2017-2022) 4.2 Global Radioimmunotherapy Concentration Ratio (CR) 4.2.1 Radioimmunotherapy Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Radioimmunotherapy in 2021 4.2.3 Global Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Radioimmunotherapy Headquarters, Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Type 4.3.1 Global Radioimmunotherapy Headquarters and Area Served 4.3.2 Global Radioimmunotherapy Companies Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Radioimmunotherapy Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Radioimmunotherapy Market Size by Company 4.5.1 Top Radioimmunotherapy Players in United States, Ranked by Revenue (2021) 4.5.2 United States Radioimmunotherapy Revenue by Players (2020, 2021 & 2022) 5 Global Radioimmunotherapy Market Size by Region 5.1 Global Radioimmunotherapy Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Radioimmunotherapy Market Size by Region (2017-2028) 5.2.1 Global Radioimmunotherapy Market Size by Region: 2017-2022 5.2.2 Global Radioimmunotherapy Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Radioimmunotherapy Market Size YoY Growth 2017-2028 6.1.2 North America Radioimmunotherapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Radioimmunotherapy Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Radioimmunotherapy Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Radioimmunotherapy Market Size YoY Growth 2017-2028 6.3.2 Europe Radioimmunotherapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Radioimmunotherapy Market Size YoY Growth 2017-2028 6.4.2 Latin America Radioimmunotherapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Radioimmunotherapy Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Radioimmunotherapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Bayer Healthcare Pharmaceuticals 7.1.1 Bayer Healthcare Pharmaceuticals Company Details 7.1.2 Bayer Healthcare Pharmaceuticals Business Overview 7.1.3 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Introduction 7.1.4 Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) 7.1.5 Bayer Healthcare Pharmaceuticals Recent Development 7.2 BioSynthema 7.2.1 BioSynthema Company Details 7.2.2 BioSynthema Business Overview 7.2.3 BioSynthema Radioimmunotherapy Introduction 7.2.4 BioSynthema Revenue in Radioimmunotherapy Business (2017-2022) 7.2.5 BioSynthema Recent Development 7.3 Clarity Pharmaceuticals 7.3.1 Clarity Pharmaceuticals Company Details 7.3.2 Clarity Pharmaceuticals Business Overview 7.3.3 Clarity Pharmaceuticals Radioimmunotherapy Introduction 7.3.4 Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) 7.3.5 Clarity Pharmaceuticals Recent Development 7.4 Curasight 7.4.1 Curasight Company Details 7.4.2 Curasight Business Overview 7.4.3 Curasight Radioimmunotherapy Introduction 7.4.4 Curasight Revenue in Radioimmunotherapy Business (2017-2022) 7.4.5 Curasight Recent Development 7.5 Endocyte 7.5.1 Endocyte Company Details 7.5.2 Endocyte Business Overview 7.5.3 Endocyte Radioimmunotherapy Introduction 7.5.4 Endocyte Revenue in Radioimmunotherapy Business (2017-2022) 7.5.5 Endocyte Recent Development 7.6 Immunomedics 7.6.1 Immunomedics Company Details 7.6.2 Immunomedics Business Overview 7.6.3 Immunomedics Radioimmunotherapy Introduction 7.6.4 Immunomedics Revenue in Radioimmunotherapy Business (2017-2022) 7.6.5 Immunomedics Recent Development 7.7 Molecular Insight Pharmaceuticals 7.7.1 Molecular Insight Pharmaceuticals Company Details 7.7.2 Molecular Insight Pharmaceuticals Business Overview 7.7.3 Molecular Insight Pharmaceuticals Radioimmunotherapy Introduction 7.7.4 Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) 7.7.5 Molecular Insight Pharmaceuticals Recent Development 7.8 Nordic Nanovector 7.8.1 Nordic Nanovector Company Details 7.8.2 Nordic Nanovector Business Overview 7.8.3 Nordic Nanovector Radioimmunotherapy Introduction 7.8.4 Nordic Nanovector Revenue in Radioimmunotherapy Business (2017-2022) 7.8.5 Nordic Nanovector Recent Development 7.9 PDL Biopharma 7.9.1 PDL Biopharma Company Details 7.9.2 PDL Biopharma Business Overview 7.9.3 PDL Biopharma Radioimmunotherapy Introduction 7.9.4 PDL Biopharma Revenue in Radioimmunotherapy Business (2017-2022) 7.9.5 PDL Biopharma Recent Development 7.10 Philogen 7.10.1 Philogen Company Details 7.10.2 Philogen Business Overview 7.10.3 Philogen Radioimmunotherapy Introduction 7.10.4 Philogen Revenue in Radioimmunotherapy Business (2017-2022) 7.10.5 Philogen Recent Development 7.11 RadioMedix 7.11.1 RadioMedix Company Details 7.11.2 RadioMedix Business Overview 7.11.3 RadioMedix Radioimmunotherapy Introduction 7.11.4 RadioMedix Revenue in Radioimmunotherapy Business (2017-2022) 7.11.5 RadioMedix Recent Development 7.12 Stella Pharma 7.12.1 Stella Pharma Company Details 7.12.2 Stella Pharma Business Overview 7.12.3 Stella Pharma Radioimmunotherapy Introduction 7.12.4 Stella Pharma Revenue in Radioimmunotherapy Business (2017-2022) 7.12.5 Stella Pharma Recent Development 7.13 Telix Pharmaceuticals 7.13.1 Telix Pharmaceuticals Company Details 7.13.2 Telix Pharmaceuticals Business Overview 7.13.3 Telix Pharmaceuticals Radioimmunotherapy Introduction 7.13.4 Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) 7.13.5 Telix Pharmaceuticals Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Radioimmunotherapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Radioimmunotherapy Market Trends Table 3. Radioimmunotherapy Market Drivers Table 4. Radioimmunotherapy Market Challenges Table 5. Radioimmunotherapy Market Restraints Table 6. Global Radioimmunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Radioimmunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Radioimmunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Radioimmunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Radioimmunotherapy Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Radioimmunotherapy Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Radioimmunotherapy Revenue Share by Player, 2017-2022 Table 13. Global Radioimmunotherapy Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Radioimmunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2021) Table 15. Top Players of Radioimmunotherapy in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Radioimmunotherapy Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Radioimmunotherapy Players in United States Market, Ranking by Revenue (2021) Table 20. United States Radioimmunotherapy Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Radioimmunotherapy Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Radioimmunotherapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Radioimmunotherapy Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Radioimmunotherapy Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Radioimmunotherapy Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Radioimmunotherapy Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Radioimmunotherapy Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Radioimmunotherapy Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Radioimmunotherapy Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Bayer Healthcare Pharmaceuticals Company Details Table 31. Bayer Healthcare Pharmaceuticals Business Overview Table 32. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Product Table 33. Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 34. Bayer Healthcare Pharmaceuticals Recent Development Table 35. BioSynthema Company Details Table 36. BioSynthema Business Overview Table 37. BioSynthema Radioimmunotherapy Product Table 38. BioSynthema Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 39. BioSynthema Recent Development Table 40. Clarity Pharmaceuticals Company Details Table 41. Clarity Pharmaceuticals Business Overview Table 42. Clarity Pharmaceuticals Radioimmunotherapy Product Table 43. Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 44. Clarity Pharmaceuticals Recent Development Table 45. Curasight Company Details Table 46. Curasight Business Overview Table 47. Curasight Radioimmunotherapy Product Table 48. Curasight Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 49. Curasight Recent Development Table 50. Endocyte Company Details Table 51. Endocyte Business Overview Table 52. Endocyte Radioimmunotherapy Product Table 53. Endocyte Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 54. Endocyte Recent Development Table 55. Immunomedics Company Details Table 56. Immunomedics Business Overview Table 57. Immunomedics Radioimmunotherapy Product Table 58. Immunomedics Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 59. Immunomedics Recent Development Table 60. Molecular Insight Pharmaceuticals Company Details Table 61. Molecular Insight Pharmaceuticals Business Overview Table 62. Molecular Insight Pharmaceuticals Radioimmunotherapy Product Table 63. Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 64. Molecular Insight Pharmaceuticals Recent Development Table 65. Nordic Nanovector Company Details Table 66. Nordic Nanovector Business Overview Table 67. Nordic Nanovector Radioimmunotherapy Product Table 68. Nordic Nanovector Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 69. Nordic Nanovector Recent Development Table 70. PDL Biopharma Company Details Table 71. PDL Biopharma Business Overview Table 72. PDL Biopharma Radioimmunotherapy Product Table 73. PDL Biopharma Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 74. PDL Biopharma Recent Development Table 75. Philogen Company Details Table 76. Philogen Business Overview Table 77. Philogen Radioimmunotherapy Product Table 78. Philogen Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 79. Philogen Recent Development Table 80. RadioMedix Company Details Table 81. RadioMedix Business Overview Table 82. RadioMedix Radioimmunotherapy Product Table 83. RadioMedix Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 84. RadioMedix Recent Development Table 85. Stella Pharma Company Details Table 86. Stella Pharma Business Overview Table 87. Stella Pharma Radioimmunotherapy Product Table 88. Stella Pharma Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 89. Stella Pharma Recent Development Table 90. Telix Pharmaceuticals Company Details Table 91. Telix Pharmaceuticals Business Overview Table 92. Telix Pharmaceuticals Radioimmunotherapy Product Table 93. Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million) Table 94. Telix Pharmaceuticals Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Radioimmunotherapy Product Picture Figure 2. Global Radioimmunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Radioimmunotherapy Market Size 2017-2028 (US$ Million) Figure 4. United States Radioimmunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Radioimmunotherapy Market Size 2017-2028 (US$ Million) Figure 6. United States Radioimmunotherapy Market Share in Global 2017-2028 Figure 7. Radioimmunotherapy Report Years Considered Figure 8. Product Picture of Non Hodgkin Lymphoma (NHL) Figure 9. Product Picture of Follicular Lymphoma Figure 10. Product Picture of Solid Tumors Figure 11. Product Picture of Breast Cancer Figure 12. Product Picture of Ovarian Cancer Figure 13. Product Picture of Osteosarcoma Figure 14. Product Picture of Neuroblastoma Figure 15. Product Picture of Prostate Cancer Figure 16. Global Radioimmunotherapy Market Share by Type in 2022 & 2028 Figure 17. Global Radioimmunotherapy Market Size by Type (2017-2028) & (US$ Million) Figure 18. Global Radioimmunotherapy Market Share by Type (2017-2028) Figure 19. United States Radioimmunotherapy Market Share by Type in 2022 & 2028 Figure 20. United States Radioimmunotherapy Market Size by Type (2017-2028) & (US$ Million) Figure 21. United States Radioimmunotherapy Market Share by Type (2017-2028) Figure 22. Product Picture of Tumor Antigens Figure 23. Product Picture of Radionuclides Figure 24. Product Picture of Antibodies Figure 25. Global Radioimmunotherapy Market Share by Application in 2022 & 2028 Figure 26. Global Radioimmunotherapy Market Size by Application (2017-2028) & (US$ Million) Figure 27. Global Radioimmunotherapy Market Share by Application (2017-2028) Figure 28. United States Radioimmunotherapy Market Share by Application in 2022 & 2028 Figure 29. United States Radioimmunotherapy Market Size by Application (2017-2028) & (US$ Million) Figure 30. United States Radioimmunotherapy Market Share by Application (2017-2028) Figure 31. North America Radioimmunotherapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. U.S. Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Canada Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Europe Radioimmunotherapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. Germany Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. France Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. U.K. Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Italy Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Russia Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Asia-Pacific Radioimmunotherapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 41. China Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Japan Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. South Korea Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. India Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Australia Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Taiwan Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Indonesia Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Thailand Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Malaysia Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Philippines Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Latin America Radioimmunotherapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 52. Mexico Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Brazil Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Argentina Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. Middle East & Africa Radioimmunotherapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 56. Turkey Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 57. Saudi Arabia Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 58. UAE Radioimmunotherapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 59. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 60. BioSynthema Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 61. Clarity Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 62. Curasight Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 63. Endocyte Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 64. Immunomedics Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 65. Molecular Insight Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 66. Nordic Nanovector Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 67. PDL Biopharma Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 68. Philogen Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 69. RadioMedix Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 70. Stella Pharma Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 71. Telix Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

Bayer Healthcare Pharmaceuticals BioSynthema Clarity Pharmaceuticals Curasight Endocyte Immunomedics Molecular Insight Pharmaceuticals Nordic Nanovector PDL Biopharma Philogen RadioMedix Stella Pharma Telix Pharmaceuticals